GVS
870976
Hangzhou CNCR-IT
300250
Shanghai Newtouch Software
688590
4
Ucap Cloud Information Technology Co.,Ltd
688228
5
Yangtze Optical Electronic
688143
US Stock MarketDetailed Quotes
NYMXF Nymox Pharmaceutical
- 0.080
- -0.030-27.27%
15min DelayTrading Jan 24 09:30 ET
7.48MMarket Cap-0.80P/E (TTM)
0.080High0.080Low3.30KVolume0.080Open0.110Pre Close264.24Turnover0.01%Turnover RatioLossP/E (Static)93.54MShares1.40052wk High-1.19P/B3.62MFloat Cap0.00052wk Low--Dividend TTM45.29MShs Float13.625Historical High--Div YieldTTM0.00%Amplitude0.000Historical Low0.080Avg Price1Lot Size
About Nymox Pharmaceutical Company
Nymox Pharmaceutical Corp. operates as a biopharmaceutical company, which engages in the research and development on products for the aging population. Its products include NicAlert, TobacAlert and Fexapotide Triflutate for the treatment of low-grade localized prostate cancer. It operates through the following geographical segments: Canada, United States, and Europe. The company was founded by Paul Averback on May 30, 1995 and is headquartered in Nassau, the Bahamas.
Company Profile
SymbolNYMXF
Company NameNymox Pharmaceutical
Listing DateNov 26, 1997
Founded1995
CEODr. Paul Averback,M.D.,D.A.B.P.
MarketPink Market
Employees9
Fiscal Year Ends12-31
AddressBay & Deveaux Streets,2nd Floor
CityNassau
ProvinceNew Providence
CountryBahamas (the)
Phone1-800-936-9669
Websitehttp://www.nymox.com
Company Executives
- Name
- Position
- Salary
- PatrickA. Doody
- Vice President and General Counsel
- --
- Paul Averback
- President and Director
- --
- James G. Robinson
- Director
- --
- David Morse
- Director
- --
- Suresh Kalbag
- Director
- --
Trending Stocks
Discussing
January rate meeting coming! Fed's pause in rate cuts a foregone conclusion?
🎙️Discussion 1. Will the Fed press the "pause button" on rate cuts as expected? 2. Do you think President Trump's political actions will ch
In One Chart
Jan 15 22:05
Here's the Breakdown for December CPI, in One Chart